Sanuwave Health, Inc. SNWV 深 滬
等待開盤 09-30 09:30:00 美东时间
34.60
+0.200
+0.58%
華盛通- 最 高38.35
- 今 開34.65
- 成交量 7.77万股
- 最 低 34.50
- 昨 收 34.40
- 總市值 2.96亿
- 52周最高 46.585
- 市盈率 靜 --
- 換手率 0.91%
- 52周最低 24.80
- 委 比 77.51%
- 總股本 856.80万
- 歷史最高 46.585
- 量 比 1.18
- 振 幅 11.19%
- 歷史最低 24.80
- 每 手 1
- 風險率
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Sanuwave refinances debt with new credit facility
Sanuwave Health (NASDAQ:SNWV) has announced the refinancing of its $27.5M debt facility with a $23.0M new secured credit facility from J.P. Morgan, 1.0M withdrawn from a two-year $5.0M revolving credi...
09-26 22:46
Sanuwave Announces Strategic Debt Refinancing with New Credit Facility
<p><p align="center"><em>Credit facility from J.P. Morgan consists of a four-year term loan of $23 million and a two-year $5 million revolving credit facility backed by accounts receivable</em></p> <p align="center"><em>Both the term loan and revolver have an interest rate of SOFR +350bp</em></p> <p align="center"><em>The Company drew approximately $1 million from the revolver at commencement, resulting in total outstanding debt under the new fac...
09-26 11:00
美股大行评级 | 潜在涨幅403.28%！瑞杰金融首予Kalaris Therapeutics"强烈买入"评级，目标价23美元
今日重点评级关注：花旗：维持Ionis Pharmaceuticals"买入"评级，目标价从69美元升至84美元；Melius Research：上调康明斯评级至"买入"，目标价500美元
09-04 09:49
Northland Capital Markets Initiates Coverage On SANUWAVE Health with Outperform Rating, Announces Price Target of $55
Northland Capital Markets analyst Carl Byrnes initiates coverage on SANUWAVE Health (NASDAQ:SNWV) with a Outperform rating and announces Price Target of $55.
09-04 02:13
美股大行评级 | 英伟达、Snowflake、万国数据、沃尔玛、Target等均获大行上调目标价
今日重点评级关注：杰富瑞：维持aTyr Pharma"买入"评级，目标价从9美元升至17美元；花旗：维持Ionis制药"买入"评级，目标价从65美元升至69美元
08-25 08:34
Sanuwave Health rises after $5M payment related to patent sale
Sanuwave (NASDAQ:SNWV) shares rose after it announced that it has received a $5M cash payment from its third-party licensee in connection with the exercise of a previously granted acquisition option. ...
08-23 03:11
Roth Capital Maintains Buy on SANUWAVE Health, Raises Price Target to $55
Roth Capital analyst Kyle Bauser maintains SANUWAVE Health (NASDAQ:SNWV) with a Buy and raises the price target from $54 to $55.
08-23 01:19
Sanuwave Receives $5M from Patent Acquisition
Sanuwave Health ( ($SNWV) ) has provided an announcement. Sanuwave, Inc. entere...
08-22 04:56
Sanuwave Health Stockholders Approve Key Proposals
An announcement from Sanuwave Health ( ($SNWV) ) is now available. On August 19...
08-21 05:20
Sanuwave Health Reports Record Q2 Revenue Growth
SANUWAVE Health Inc. ( ($SNWV) ) has released its Q2 earnings. Here is a breakd...
08-09 12:17
